Literature DB >> 25730336

Choroidal neovascularization associated with extensive macular atrophy and pseudodrusen.

Maurizio Battaglia Parodi1, Giuseppe Querques.   

Abstract

PURPOSE: To describe a case of extensive macular atrophy and pseudodrusen complicated by bilateral choroidal neovascularization (CNV).
METHODS: A 53-year-old woman showed extensive macular atrophy at the posterior pole associated with disciform scar in the right eye and fibrotic juxtafoveal CNV in the left eye.
RESULTS: The patient underwent a complete ophthalmological examination including fundus autofluorescence, fluorescein angiography, and spectral-domain optical coherence tomography, showing a disciform scar at the posterior pole of the right eye and an extensive macular atrophy associated with a fibrotic juxtafoveal CNV. The patient was previously treated with four and seven intravitreal bevacizumab injections, respectively, in the right eye and in the left eye. Molecular analyses of the ABCA4 gene revealed the variant c.1268A<G.
CONCLUSIONS: Although the natural course of extensive macular atrophy and pseudodrusen usually leads to the enlargement of the macular atrophy, extensive macular atrophy and pseudodrusen can also complicate with bilateral CNV. Intravitreal bevacizumab can help stop the CNV activity.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25730336     DOI: 10.1097/OPX.0000000000000532

Source DB:  PubMed          Journal:  Optom Vis Sci        ISSN: 1040-5488            Impact factor:   1.973


  2 in total

1.  Optical Coherence Tomography Angiography in Extensive Macular Atrophy with Pseudodrusen-Like Appearance.

Authors:  Firuzeh Rajabian; Alessandro Arrigo; Alessandro Bordato; Stefano Mercuri; Francesco Bandello; Maurizio Battaglia Parodi
Journal:  Transl Vis Sci Technol       Date:  2020-02-07       Impact factor: 3.283

2.  Progression of Atrophy and Visual Outcomes in Extensive Macular Atrophy with Pseudodrusen-like Appearance.

Authors:  Francesco Romano; Matteo Airaldi; Mariano Cozzi; Marta Oldani; Ester Riva; Alice Ingrid Bertoni; Astrit Dautaj; Matteo Bertelli; Giovanni Staurenghi; Anna Paola Salvetti
Journal:  Ophthalmol Sci       Date:  2021-03-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.